Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.12
-0.4000-1.40%
Post-market: 28.12-0.00050.00%19:59 EDT
Volume:30.49M
Turnover:861.16M
Market Cap:159.88B
PE:37.01
High:28.59
Open:28.45
Low:28.08
Close:28.52
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.99
T/O Rate:0.54%
Dividend:1.72
Dividend Rate:6.12%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.88
PE(LYR):20.61

Loading ...

Movement Alert|Pfizer Rises 3.02% in Regular Trading, CEO First Personal Share Purchase Signals Confidence

Market Focus
·
Aug 19

Pfizer Pick of the Week at Smart Insider Following CEO's First Share Purchase

MT Newswires Live
·
Aug 18

Press Release: J.P. Morgan Life Sciences Private Capital Welcomes Bruce N. Rogers, Ph.D. as Venture Partner

Dow Jones
·
Aug 18

Moderately bullish activity in Pfizer with shares up 0.21%

TIPRANKS
·
Aug 18

Pfizer Insider Buying Surge and Vaccine Wins Ignite Buzz

TIPRANKS
·
Aug 15

Intel, Netflix, Pfizer, Coca-Cola, J&J Insider Shock

TIPRANKS
·
Aug 15

NYSE Most Active Issues

Dow Jones
·
Aug 15

Pfizer’s Korean Paxlovid Study Signals Ongoing Value in High‑Risk COVID Market

TIPRANKS
·
Aug 15

Sector Update: Healthcare Stocks Flat to Lower Pre-Bell Friday

MT Newswires Live
·
Aug 14

Barclays Sticks to Their Sell Rating for Pfizer (PFE)

TIPRANKS
·
Aug 14

Valneva Se Shares up 12% to Top of Sbf 120 Index After Ema Validates Pfizer and Valneva's Lyme Disease Vaccine Application

THOMSON REUTERS
·
Aug 14

Valneva, Pfizer Lyme Vaccine Application Clears EMA Validation Step

Reuters
·
Aug 14

2026 Health Industry Summit Explores Pharmacy Evolution: From Drug Retailers to Community Wellness Hubs

Stock News
·
Aug 13

Pfizer (PFE) Could Be 10% Undervalued Following Raised Revenue Guidance

Simply Wall St.
·
Aug 13

Valneva Falls After H1 Revenue, Operating Profit Drop

Reuters
·
Aug 13

Valneva H1 FY26 Net Loss Widens to EUR 63.28 Million; Revenue Drops 32.51% to EUR 65.84 Million

Reuters
·
Aug 13

Pfizer Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Pfizer CEO Albert Bourla Acquires $1,000,920 of Common Shares

Reuters
·
Aug 13

Press Release: Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results

Dow Jones
·
Aug 12

Daiwa Securities Adjusts Price Target on Pfizer to $27 From $28, Maintains Neutral Rating

MT Newswires Live
·
Aug 12